Zhenhua Du

737 total citations
24 papers, 538 citations indexed

About

Zhenhua Du is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zhenhua Du has authored 24 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Zhenhua Du's work include Endometrial and Cervical Cancer Treatments (3 papers), MicroRNA in disease regulation (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Zhenhua Du is often cited by papers focused on Endometrial and Cervical Cancer Treatments (3 papers), MicroRNA in disease regulation (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Zhenhua Du collaborates with scholars based in China, United States and Hong Kong. Zhenhua Du's co-authors include Ying Jin, Jiqin Liu, Hua Zhang, Yu Xia, Lei Wang, Gangjun Du, Hui Qü, Lei Wang, Qing Yang and Fangfang Bi and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Zhenhua Du

22 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenhua Du China 12 357 236 74 42 38 24 538
Chong-Zhen Qin China 13 350 1.0× 260 1.1× 40 0.5× 26 0.6× 20 0.5× 22 507
Stéphanie Jean Canada 11 428 1.2× 116 0.5× 132 1.8× 19 0.5× 28 0.7× 24 539
Xu Xiao China 11 390 1.1× 156 0.7× 49 0.7× 33 0.8× 35 0.9× 24 456
Yunfeng Zhou China 14 328 0.9× 270 1.1× 63 0.9× 32 0.8× 27 0.7× 38 531
Yating Xu China 11 239 0.7× 138 0.6× 23 0.3× 28 0.7× 21 0.6× 37 375
Yingying Liu China 16 503 1.4× 446 1.9× 89 1.2× 58 1.4× 13 0.3× 39 752
Jingwei Zhang China 16 745 2.1× 561 2.4× 95 1.3× 55 1.3× 18 0.5× 42 956
Miaolong Lu China 12 364 1.0× 225 1.0× 87 1.2× 32 0.8× 7 0.2× 18 607
Wujun Xiong China 14 387 1.1× 291 1.2× 73 1.0× 52 1.2× 7 0.2× 18 571
Xiaowen Hu China 10 380 1.1× 109 0.5× 175 2.4× 42 1.0× 13 0.3× 20 555

Countries citing papers authored by Zhenhua Du

Since Specialization
Citations

This map shows the geographic impact of Zhenhua Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenhua Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenhua Du more than expected).

Fields of papers citing papers by Zhenhua Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenhua Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenhua Du. The network helps show where Zhenhua Du may publish in the future.

Co-authorship network of co-authors of Zhenhua Du

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenhua Du. A scholar is included among the top collaborators of Zhenhua Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenhua Du. Zhenhua Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Du, Zhenhua, et al.. (2024). From lab to clinic: The discovery and optimization journey of PI3K inhibitors. European Journal of Medicinal Chemistry. 277. 116786–116786. 5 indexed citations
3.
Li, Yuzhao, Zhenhua Du, Jian Han, et al.. (2023). Identification of oil–water-gas flow patterns by super-sparse near-infrared wavelengths sensor. Infrared Physics & Technology. 133. 104854–104854. 9 indexed citations
4.
Liu, Xiaomei, Zhifeng Xiao, Song Yang, et al.. (2021). A Machine Learning-Aided Framework to Predict Outcomes of Anti-PD-1 Therapy for Patients With Gynecological Cancer on Incomplete Post-Marketing Surveillance Dataset. IEEE Access. 9. 120464–120480. 5 indexed citations
5.
Du, Zhenhua, Lei Wang, & Yu Xia. (2020). Circ_0015756 promotes the progression of ovarian cancer by regulating miR-942-5p/CUL4B pathway. Cancer Cell International. 20(1). 572–572. 26 indexed citations
6.
Du, Zhenhua, Xinyi Liu, Xiao‐Jun Wei, et al.. (2020). Quantitative proteomics identifies a plasma multi-protein model for detection of hepatocellular carcinoma. Scientific Reports. 10(1). 15552–15552. 24 indexed citations
8.
Wang, Lei, et al.. (2019). A six‐CpG‐based methylation markers for the diagnosis of ovarian cancer in blood. Journal of Cellular Biochemistry. 121(2). 1409–1419. 5 indexed citations
9.
Liu, Jiqin, et al.. (2018). m 6 A demethylase FTO facilitates tumor progression in lung squamous cell carcinoma by regulating MZF1 expression. Biochemical and Biophysical Research Communications. 502(4). 456–464. 203 indexed citations
10.
Chen, Hua, Junyi Gao, Zhenhua Du, et al.. (2018). Expression of factors and key components associated with the PI3K signaling pathway in colon cancer. Oncology Letters. 15(4). 5465–5472. 11 indexed citations
11.
Yao, Jingjing, Zhenhua Du, Zibo Li, et al.. (2018). 6-Gingerol as an arginase inhibitor prevents urethane-induced lung carcinogenesis by reprogramming tumor supporting M2 macrophages to M1 phenotype. Food & Function. 9(9). 4611–4620. 35 indexed citations
12.
Du, Zhenhua, Fangfang Bi, Lei Wang, & Qing Yang. (2018). Next‐generation sequencing unravels extensive genetic alteration in recurrent ovarian cancer and unique genetic changes in drug‐resistant recurrent ovarian cancer. Molecular Genetics & Genomic Medicine. 6(4). 638–647. 27 indexed citations
13.
Yang, Fei, Junyi Gao, Hua Chen, et al.. (2017). Targeted inhibition of the phosphoinositide 3-kinase impairs cell proliferation, survival, and invasion in colon cancer. OncoTargets and Therapy. Volume 10. 4413–4422. 18 indexed citations
15.
Xia, Yu, Zhenhua Du, Xinyan Wang, & Xiuqin Li. (2017). Treatment of Uterine Sarcoma with rAd-p53 (Gendicine) Followed by Chemotherapy: Clinical Study of TP53 Gene Therapy. Human Gene Therapy. 29(2). 242–250. 21 indexed citations
16.
Guo, Zhenzhen, Mingjing Meng, Zhenhua Du, et al.. (2016). The optimal dose of arsenic trioxide induced opposite efficacy in autophagy between K562 cells and their initiating cells to eradicate human myelogenous leukemia. Journal of Ethnopharmacology. 196. 29–38. 10 indexed citations
17.
Zheng, Yaqiu, Mingjing Meng, Zhenzhen Guo, et al.. (2016). Gingerol Reverses the Cancer-Promoting Effect of Capsaicin by Increased TRPV1 Level in a Urethane-Induced Lung Carcinogenic Model. Journal of Agricultural and Food Chemistry. 64(31). 6203–6211. 34 indexed citations
18.
Du, Zhenhua & Xiaolin Ma. (2015). Dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin treatment for stage II-IV ovarian cancer patients. Bangladesh Journal of Pharmacology. 10(3). 489–489. 2 indexed citations
19.
Tracey, Lorraine, Christian J. Streck, Zhenhua Du, et al.. (2010). NF-κB activation mediates resistance to IFNβ in MLL-rearranged acute lymphoblastic leukemia. Leukemia. 24(4). 806–812. 14 indexed citations
20.
Li, Xiuqin, Bo Ren, & Zhenhua Du. (2008). Effect of activin A on OVCAR-3 Ovarian epithelial cancer cells. Chinese Journal of Cancer Research. 20(3). 186–189. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026